Skip to content
  • Instagram
  • YouTube
  • X

PharmaBR.News

  • About Us

Patient safety

  • Brazil warns of rising counterfeit risks as high-value medicines top falsification list
    20 de November de 2025

    Brazil warns of rising counterfeit risks as high-value medicines top falsification list

    pietrorubin
  • Brazil associations discuss strategies to combat medicine counterfeiting
    6 de November de 2025

    Brazil associations discuss strategies to combat medicine counterfeiting

    pharmabrnews
  • Brazil’s illicit market for obesity medications surges, raising public-health alarm
    1 de November de 2025

    Brazil’s illicit market for obesity medications surges, raising public-health alarm

    pharmabrnews
  • Brazil’s Anvisa updates status of gene therapy for Duchenne muscular dystrophy
    30 de October de 2025

    Brazil’s Anvisa updates status of gene therapy for Duchenne muscular dystrophy

    pharmabrnews
  • Brazil’s Anvisa steps up response to counterfeit semaglutide and unregistered anabolic drugs
    29 de October de 2025

    Brazil’s Anvisa steps up response to counterfeit semaglutide and unregistered anabolic drugs

    pharmabrnews
  • Anvisa prohibits falsified lots of cancer drugs in Brazil
    22 de October de 2025

    Anvisa prohibits falsified lots of cancer drugs in Brazil

    pietrorubin

Categories

Reviews.

News.

Guides.

Deals.

Videos.

Reader Poll.

Features.

Staff Picks.

Game Culture.

Podcast.

At PharmaBR.News, we highlight key developments in Brazil’s pharmaceutical and health policy landscape.

Get our free weekly briefing straight to your inbox.

  • Instagram
  • YouTube
  • X
  • About Us

Designed with WordPress

Loading Comments...